REGULATED PRESS RELEASE published on 09/20/2024 at 17:40, 2 months ago Availability of the 2024 Half-Year Financial Report ALTEN SA files its 2024 Half-Year Financial Report with the French financial markets authority, available on the company's website. ALTEN is a European leader in Engineering and Technology Consulting Technology Consulting French Financial Markets Authority ALTEN SA Engineering Half-year Financial Report
BRIEF published on 09/19/2024 at 17:45, 2 months 1 day ago ALTEN 2024 half-year results: moderate growth Acquisitions Organic Growth Half-year Results Operating Result France And International
BRIEF published on 09/19/2024 at 17:45, 2 months 1 day ago ALTEN: 2024 First-Half Results Acquisitions ALTEN Operating Margin Financial Earnings First-half Results
REGULATED PRESS RELEASE published on 09/19/2024 at 17:40, 2 months 1 day ago ALTEN: 2024 First-Half results ALTEN reports moderate organic growth of 0.9% in first half 2024 with key financial highlights such as operating margin of 8.4% and net profit increase by 6.4% year-on-year Financial Results Organic Growth ALTEN Net Profit Operating Margin
BRIEF published on 09/06/2024 at 17:50, 2 months 14 days ago ALTEN Announces Share and Voting Rights Information for August 2024 Euronext Paris Voting Rights Shares Disclosure ALTEN
REGULATED PRESS RELEASE published on 09/06/2024 at 17:45, 2 months 14 days ago August 2024 ALTEN SA releases information on total number of shares and voting rights, in compliance with regulations. The company is a European leader in Engineering and Technology Consulting Voting Rights Technology Consulting Total Number Of Shares ALTEN SA Engineering
BRIEF published on 08/06/2024 at 17:50, 3 months 14 days ago ALTEN Announces Share and Voting Rights Update for July 2024 Euronext Paris Voting Rights ALTEN July 2024 Shares Update
REGULATED PRESS RELEASE published on 08/06/2024 at 17:45, 3 months 14 days ago July 2024 ALTEN SA discloses information on outstanding shares and voting rights pursuant to French commercial regulations. Company specializes in Engineering and IT Services Voting Rights Outstanding Shares ALTEN SA French Commercial Regulations Engineering And IT Services
BRIEF published on 07/25/2024 at 17:45, 3 months 26 days ago ALTEN: Business in First Half 2024 Revenue Acquisitions ALTEN Growth H1 2024
BRIEF published on 07/25/2024 at 17:45, 3 months 26 days ago ALTEN: Activity for the first half of 2024 Acquisitions International Growth Forecast 2024 Turnover
Published on 11/21/2024 at 13:30, 23 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 23 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 53 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 53 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 53 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
